Bar charts showing the numbers of significantly differentially expressed genes for the different contrasts. by Gillian P. McHugo (8965919)

“…<p>The extent of the bar above and below 0 on the vertical axis indicates the numbers of significantly differentially expressed genes (DEGs; B-H <i><i>P</i></i><sub>adj.…”

Join-point regression analysis of the statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

Subjects:

PBM significantly reduces hyperphosphorylation of tau with no effect on total tau expression. by Kevin J. Johnson (2647639)

ATGL-1 levels increase and lipid droplets decrease in response to <i>N. parisii</i> infection. by Hala Tamim El Jarkass (16625309)

Subjects:

Penalty conversions yield large practical decreases, but robustness and generalizability of result are limited by data quality and sample selection. by Ryan J. Treves (13527735)

Demographic information of participants. by Zixia Bu (21475019)

Subjects:

Difference in various variables with different PA level. by Zixia Bu (21475019)

Subjects:

Characterization and difference in various variables with different PA level. by Zixia Bu (21475019)

Subjects:

Correlation results between PA and different table variables. by Zixia Bu (21475019)

Subjects:

Correlation heatmap between physical activity and individual variables. by Zixia Bu (21475019)

Subjects:

Cross-lagged panel model based on physical activity, aggressive behavior and Chinese language learning. by Zixia Bu (21475019)

Subjects:

Cross-lagged panel model consistency test based on physical activity, aggressive behavior and Chinese language learning. by Zixia Bu (21475019)

Subjects:

Comparison of the fit of multiple cluster analyses of the cross-lagged panel model. by Zixia Bu (21475019)

Subjects:

Socio-demographic and medical characteristics of patients with liver cancer. by Ayana Ablayeva (22103708)

Subjects:

Data cleaning and preparation algorithm. by Ayana Ablayeva (22103708)

Subjects:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

Subjects:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects: